All News
Filter News
Found 139 articles
-
Johnson & Johnson Release: New Data Show On-Demand, Mealtime Insulin Delivery System Enabled More Than 50 Percent Of Patients To Report Improved Dose Compliance
6/14/2016
-
Globus Medical Appoints Eric Ian Schwartz As Senior Vice President And General Counsel On A First Date Has Been Created
5/11/2016
-
touchENDOCRINOLOGY An Update On The Hypoglycaemia-Hyperglycaemia Minimizer System In The Management Of Type 1 Diabetes
4/21/2016
-
LifeScan, Inc. Announces Strategic Collaboration With WellDoc To Advance Mobile Care Solutions For Type 2 Diabetes Patients
3/1/2016
-
LifeScan, Inc. Release: New OneTouch Verio Flex Blood Glucose Monitoring System With ColorSure Technology Takes The Guesswork Out Of Blood Sugar Test Results
2/24/2016
-
Johnson & Johnson Reports 2015 Fourth-Quarter Results
1/26/2016
-
FDA Approves Animas Corporation Vibe Insulin Pump and Continuous Glucose Monitoring System For Use in Children
1/11/2016
-
Johnson & Johnson Diabetes Solutions Companies Release: OneTouch Reveal App for Diabetes Management Adds Support For HealthKit
11/12/2015
-
Janssen Research & Development Sets A Course To Intercept Type 1 Diabetes Together With JDRF
2/12/2015
-
Zynerba Appoints Richard A. Baron VP And CFO
1/5/2015
-
Animas Corporation Vibe Insulin Pump And Continuous Glucose Monitoring System Receives FDA Approval
12/1/2014
-
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute For Technology Translation (JITT) As Founding Members
10/30/2014
-
Medtronic, Inc., Johnson & Johnson Settle Patent Spat
8/14/2014
-
Advances In Predictive Hypoglycemia-Minimizing Technology From Animas Corporation-JDRF Collaboration At American Diabetes Association Scientific Sessions
6/16/2014
-
Animas Corporation Release: Animas® Vibe Insulin Pump And Dexcom G4 PLATINUM CGM System Is Now Approved For Children With Type 1 Diabetes
3/6/2014
-
Continuous Glucose Monitoring (CGM) Market Will Reach $568.5 Million Globally By 2020 - Allied Market Research
12/23/2013
-
Hacker Demonstrates Just How Vulnerable Johnson & Johnson's Insulin Pump Really Is
8/2/2013
-
Animas Corporation Makes Progress in Development of a First-Generation Closed-Loop Insulin Delivery System With Study Participants Maintaining Safe Glucose Levels for Over 90 Percent of the Overnight Period
6/24/2013
-
A Real False Alarm: Johnson & Johnson Recalls Another Product
4/8/2013
-
FDA Approves Johnson & Johnson's New Diabetes Drug
4/8/2013